Home
Anti Ageing Therapies
23 October - 24 October 2002
Anti Ageing Therapies
Scientists are treating ageing more and more as a disease, as opposed to an inevitable pathway that we all will follow. The ‘cure’ for ageing is perhaps still thought of by most as a fanciful idea that, even if possible, certainly lies a long way in the future. However, with our increasing understanding of the ageing process and the discovery of new methods and products to detect, delay and treat age-related undesirables and diseases, achieving healthier and longer lives seems well within our grasp.

SAE Media Group has identified this as a key time to provide updates on developments in this industry. The conference will take a detailed look at new revelations in terms of the molecular, genetic and endocrinological basis to the ageing process. It will evaluate leading research trends for the discovery and development of anti-ageing therapies. This will include a focus on mitochondria, telomeres and stem cell technology as mechanisms of rejuvenation. The programme will also investigate recent developments in the treatment of age-associated diseases, including cancer, heart disease, diabetes and Alzheimer’s.

You will have plenty of opportunity to network and exchange ideas with experts in this industry, which has the potential to explode in the next few years.

Conference agenda

clock

8:30

Registration and Coffee

clock

9:00

Chairman's Opening Remarks

Dr Alan Hipkiss

Dr Alan Hipkiss, Senior Lecturer, Biochemistry, King’s College London

clock

9:20

ANTI-AGEING THERAPEUTICS: AN INTRODUCTION

Dr Bryant Villeponteau

Dr Bryant Villeponteau, President & Chief Scientific Officer, HealthSpan Sciences

  • Should one develop therapies for ageing or age-related diseases?
  • Major proposed causes of ageing
  • Summary of recent data supporting each cause of ageing
  • Causes versus effects: does treating effects of ageing help?
  • Therapies that address each proposed cause of ageing
  • Best anti-ageing targets based on current data
  • clock

    9:50

    ENDOCRINOLOGY OF AGEING

    Dr Jan Nehlin

    Dr Jan Nehlin, Scientist & Research Associate Professor, Novo Nordisk

  • Many hormones decline in their frequency, strength and production as we age
  • What are the underlying mechanisms responsible?
  • Relative magnitudes and time courses of different endocrine adaptations in the ageing human and in experimental animals
  • The current focuses: HGH, DHEA, cortisol, melatonin, thyroid hormone and thymic hormones
  • Targeting hormone precursors for anti-ageing therapies
  • Implications of therapeutic reconstitution with hormones in the aged
  • clock

    10:30

    SLOWING DOWN AGEING FROM WITHIN

    Prof Suresh Rattan

    Prof Suresh Rattan, Professor, Danish Centre for Molecular Gerontology, University of Aarhus

  • Gerontogenes
  • Vitagenes
  • Failure of maintenance
  • Homeostasis and homeodynamics
  • Stress response
  • Healthy ageing
  • clock

    11:10

    Morning Coffee

    clock

    11:30

    OXIDATIVE DAMAGE AND TARGETING ANTI-AGEING THERAPIES

    Dr Bernard Malfroy-Camine

    Dr Bernard Malfroy-Camine, President & Chief Executive Officer, Eukarion

  • Understanding oxidative stress and its role in pathogenesis and ageing
  • The anti-oxidant defence system
  • Pharmacological intervention to counteract oxidative stress: synthetic catalytic scavengers
  • Studies in animal models for diseases associated with ageing
  • Clinical development programs
  • Is oxidative stress one key to future research into ageing and age-related diseases?
  • clock

    12:10

    OXIDATIVE STRESS PROFILE

    Dr Richard Cutler

    Dr Richard Cutler, Senior Scientist, Exeter Life Sciences/ Kronos Longevity Research Institute

  • Longevity determinant genes and the dysdifferentiation hypothesis of ageing
  • Evidence for primary ageing and primary anti-ageing processes

    The genetic complexity governing human ageing rate

  • Oxidative stress represents a primary ageing process

    Processes governing oxidative stress status control stability of the differentiated cell

  • Stability of the transcription/translation profile of cells govern whole organism ageing rate

    Determining the oxidative stress/antioxidant profile of patients

  • Using the oxidative stress profile to create customised dietary supplements

    Demonstration that dietary supplements reduce patients’ oxidative stress status

  • The Kronos Laboratory tests and optimum health program
  • clock

    12:50

    Lunch

    clock

    14:00

    MITOCHONDRIA AND LYSOSOMES IN PRIMARY MECHANISMS OF HUMAN AGEING

    John Furber

    John Furber, Founder, Legendary Pharmaceuticals

  • Turnover of proteins and mitochondria in post-mitotic cells: decline with age
  • Lipofuscin origins and consequences
  • Mitochondrial DNA mutations take over cells
  • Energy crisis and redox stress cause cell senescence and cell death
  • Damage to the brain, heart and skeletal muscle
  • Design of targeted therapies
  • clock

    14:40

    MITOCHONDRIAL DYSFUNCTION IN AGEING AND DISEASE

    Dr James Dykens

    Dr James Dykens, Senior Scientist, Associate Director, Business & Corporate Development, Mitokor

  • Mitochondrial function and dysfunction in ageing
  • Oxidative mitochondrial pathology and failure
  • Mitochondrial contributions to disease (type 2 diabetes; Alzheimer’s and Parkinson’s diseases; glaucoma)
  • Polycyclic phenols (PPCs) as drug development candidates
  • Mechanisms of action and SAR
  • Mitochondrial consequences of PPC treatment

    New directions and indications

  • clock

    15:20

    Afternoon Tea

    clock

    15:40

    DRUG TARGETING AND TELOMERASE

    Dr Calvin Harley

    Dr Calvin Harley, Chief Scientific Officer, Geron

  • Telomeres in the regulation of cellular senescence
  • The shortening of telomeres appears to be the cellular clock that controls the ageing of our cells
  • The telomere and telomerase connection
  • Four approaches for killing telomerase-positive cells as cancer therapy
  • Progress towards development of telomerase activators for degenerative conditions of ageing
  • clock

    16:20

    Chairman's Closing Remarks and Close of Day One

    clock

    8:30

    Re-registration and Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Dr Wilfried Bieger

    Dr Wilfried Bieger, Private Practice, ANT.OX

    clock

    9:10

    THE AGEING BRAIN AND ALZHEIMER’S DISEASE

    Dr Bruce Gitter

    Dr Bruce Gitter, Senior Research Scientist, Eli Lilly

  • Alzheimer’s disease: the most common cause of dementia among older people
  • Using in vitro cell and transgenic animal models to investigate the amyloid hypothesis of Alzheimer’s disease pathogenesis
  • Understanding the role of amyloid precursor protein (APP) processing enzymes in the production, deposition and clearance of brain Ab deposits
  • Alternative strategies to reduce brain Ab deposits and reverse cognitive deficits in transgenic animal models of APP over expression
  • clock

    9:40

    OXIGONTM: DUAL MECHANISM APPROACH TO THE TREATMENT OF ALZHEIMER’S DISEASE

    Prof Paul Bendheim

    Prof Paul Bendheim, Executive Vice President & Chief Medical Officer, Mindset BioPharmaceuticals

  • The central role of beta-amyloid cascade in AD
  • Oxidative stress in AD
  • Therapeutic strategies for AD
  • Complexities of trial design in AD: symptomatic versus disease modifying therapies
  • OXIGONTM: a potent neuroprotective molecule
  • clock

    10:20

    A PROMISING ANTI-AMYLOID APPROACH TO ALZHEIMER’S DISEASE THERAPY

    Dr Patrick Tremblay

    Dr Patrick Tremblay, Director, Pharmacology, Neurochem

  • Glycosaminoglycans (GAGs) promote amyloid formation
  • GAG mimetics bind to amyloid protein and block amyloid formation in animal model of AD
  • GAG mimetics reduce brain inflammation associated with amyloid deposits
  • GAG mimetics: an oral drug candidate with a promising safety profile in clinical phase I trials
  • clock

    11:00

    Morning Coffee

    clock

    11:20

    BRAIN AGEING AND GLUTAMATE

    Dr Gary Rogers

    Dr Gary Rogers, Senior Vice President, Pharmaceutical Research, Cortex Pharmaceuticals

  • Glutamate: the primary neurotransmitter in the mammalian brain for excitatory communication
  • AMPA receptor activity: its significance for cognitive function
  • How much potentiation is enough: how much is too much?
  • Ampakines: increased neutrophin (BDNF and NGF) expression to slow brain ageing
  • Ampalex: the effects of CX516 in the elderly with mild cognitive impairment
  • clock

    12:00

    AGEING SKIN

    Prof Alan Husband

    Prof Alan Husband, Research Director, Novogen

  • Signs of ageing primarily caused by photo damage
  • How does our skin change: the dangers of skin immunosuppression
  • Synthetic phenolic hormones with anti-inflammatory and immunostimulatory properties
  • Topical application: the potential for protection against UV-induced skin damage and as an anti-ageing formulation
  • So called ‘anti-ageing’ creams that temporarily moisturise the skin but do not reverse damage
  • Case study: NV-07a: the ability to undo skin damage following UV exposure
  • clock

    12:40

    Lunch

    clock

    14:00

    NEW TECHNOLOGICAL SOLUTIONS TO YOUNGER SKIN

    Dr Stanley Shapiro

    Dr Stanley Shapiro, Vice President, Science and Technology, Johnson & Johnson

  • The quest for young looking skin: the need for medical intervention
  • The ‘look good’ generation and tapping into the cosmeceutical market
  • Intrinsic and extrinsic factors responsible for skin ageing
  • Common active ingredients to defy signs of ageing
  • ReNova as a skin rejuvenation treatment
  • clock

    14:40

    CELL THERAPY FOR AGE-RELATED DISEASES

    Dr Don Kleinsek

    Dr Don Kleinsek, Chief Executive Officer, GeriGene Medical

  • Stem cells
  • Cell replacement
  • Host Vs.graft reaction
  • Safety
  • Funtionality
  • Regulatory hurdles
  • clock

    15:20

    Chairman's Closing Remarks and Close of Conference, followed by Afternoon Tea

    VENUE

    The Hatton, at etc. venues

    51/53 Hatton Garden, London, United Kingdom

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    The Hatton, at etc. venues

    51/53 Hatton Garden
    London EC1N 8HN
    United Kingdom

    The Hatton, at etc. venues

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.